These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12235569)

  • 1. [The usefulness of dopaminergic drugs in traumatic brain injury].
    Orient-López F; Terre- Boliart R; Bernabeu-Guitart M; Ramón-Rona S; Pérez-Miras A
    Rev Neurol; 2002 Aug 16-31; 35(4):362-6. PubMed ID: 12235569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible applications for dopaminergic agents following traumatic brain injury: part 2.
    Zafonte RD; Lexell J; Cullen N
    J Head Trauma Rehabil; 2001 Feb; 16(1):112-6. PubMed ID: 11277855
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical treatment of later-stage motor problems of Parkinson disease.
    Ahlskog JE
    Mayo Clin Proc; 1999 Dec; 74(12):1239-54. PubMed ID: 10593354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.
    Kurlan R
    Neurology; 2005 Mar; 64(5):923-4. PubMed ID: 15753443
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dopaminergic agonists in the treatment of Parkinson's disease].
    Supiot F; Sternon J; Zegers de Beyl D
    Rev Med Brux; 2000 Dec; 21(6):493-9. PubMed ID: 11194495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Goetz CG; Poewe W; Rascol O; Sampaio C
    Mov Disord; 2005 May; 20(5):523-39. PubMed ID: 15818599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dopamine enhancing medications with children in low response states following brain injury.
    Patrick PD; Buck ML; Conaway MR; Blackman JA
    Brain Inj; 2003 Jun; 17(6):497-506. PubMed ID: 12745705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury.
    Napolitano E; Elovic EP; Qureshi AI
    Med Sci Monit; 2005 Jun; 11(6):RA212-220. PubMed ID: 15917733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New pharmacotherapy for Parkinson's disease.
    Gottwald MD; Bainbridge JL; Dowling GA; Aminoff MJ; Alldredge BK
    Ann Pharmacother; 1997 Oct; 31(10):1205-17. PubMed ID: 9337447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review.
    Kraus MF; Maki PM
    J Neuropsychiatry Clin Neurosci; 1997; 9(2):222-30. PubMed ID: 9144101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New options for treatment of Parkinson's disease.
    LeWitt PA
    Baillieres Clin Neurol; 1997 Apr; 6(1):109-23. PubMed ID: 9426871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor deficits in Parkinsonian reaching: dopa-sensitivity influenced by real-world task constraint.
    Doan J; Whishaw IQ; Pellis SM; Suchowersky O; Brown LA
    J Mot Behav; 2006 Jan; 38(1):45-59. PubMed ID: 16436362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial.
    Giacino JT; Whyte J
    J Head Trauma Rehabil; 2003; 18(1):4-5; author reply 5-6. PubMed ID: 12809123
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation.
    Karli DC; Burke DT; Kim HJ; Calvanio R; Fitzpatrick M; Temple D; Macneil M; Pesez K; Lepak P
    Brain Inj; 1999 Jan; 13(1):63-8. PubMed ID: 9972445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury.
    Kraus MF; Maki P
    Brain Inj; 1997 Jun; 11(6):455-60. PubMed ID: 9171930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study.
    Schneider WN; Drew-Cates J; Wong TM; Dombovy ML
    Brain Inj; 1999 Nov; 13(11):863-72. PubMed ID: 10579658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential time and related appearance of signs, indicating improvement in the state of consciousness in vegetative state traumatic brain injury (VS-TBI) patients after initiation of dopamine treatment.
    Krimchansky BZ; Keren O; Sazbon L; Groswasser Z
    Brain Inj; 2004 Nov; 18(11):1099-105. PubMed ID: 15545207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amantadine treatment following traumatic brain injury in children.
    Williams SE
    Brain Inj; 2007 Aug; 21(9):885-9. PubMed ID: 17729042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment in Parkinson disease].
    Takáts A
    Orv Hetil; 2004 Apr; 145(15):833-4. PubMed ID: 15188639
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET).
    Kraus MF; Smith GS; Butters M; Donnell AJ; Dixon E; Yilong C; Marion D
    Brain Inj; 2005 Jul; 19(7):471-9. PubMed ID: 16134735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.